Susceptibility of Mycobacterium tuberculosis to isoniazid and its derivative, 1-isonicotinyl-2-nonanoyl hydrazine: Investigation at cellular level

Tuberculosis

Volumn 84, Issue 1-2, 2004, Pages 56-62

  Mohamad, Suriyati ^a   Ibrahim, Pazilah ^b   Sadikun, Amirin ^b  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

1 isonicotinyl 2 nonanoyl hydrazine; Acid fastness; Cellular morphology; Isoniazid; Mycobacterium tuberculosis

Indexed keywords

1 ISONICOTINYL 2 NONANOYLHYDRAZINE; ACID; AGAR; ISONIAZID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; BACTERIAL CELL; CELL ACTIVITY; CELL CYCLE; CELL GROWTH; CELL STRUCTURE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CULTURE MEDIUM; DRUG EXPOSURE; DRUG STRUCTURE; MICROSCOPE; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STAINING; TIME;

EID: 0347092000     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2003.08.004     Document Type: Conference Paper

References (15)

1. Takayama K, Wang L, David HL. Effect of isonlazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1972;2(1):29-35.
2. Morris S, Bai GH, Suffys P, Portillo-Gomez L, Fairchok M, Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 1995;171:54-60.
3. Quemard A, Lacave C, Lanéelle G. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob Agents Chemother 1991;35(6):1035-9.
4. Winder FG, Collins PB. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J Gen Microbiol 1970;63:41-8.
5. Takayama K, Wang L, Merikal RS. Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1973;4(1):62-5.
6. Heym B, Alzari PM, Honore N, Cole ST. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 1995;15(2):235-45.
7. Zhang Y, Garbe T, Young D. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol 1993;8(3):521-4.
8. Herman RP, Webber MM. Isoniazid interaction with tyrosine as a possible mode of action of the drug In mycobacteria. Antimicrob Agents Chemother 1980;17:170-8.
9. Shoeb HA, Bowman Jr BU, Ottolenghi AC, Merola AJ. Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 1985;27(3):404-7.
10. Jacobs RF. Multiple-drug-resistant tuberculosis. Clin Infect Dis 1994;19:1-8.
11. Rastogi N, Moreau B, Capmau ML, Goh KS, David HL. Antibacterial action of amphipathic derivatives of isoniazid against the Mycobacterium avium complex. Zbl Bakt Hyg Infect Dis Virol Parasitol 1988;268:456-62.
12. Rastogi N, Goh KS, David HL. Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob Agents Chemother 1990;34:759-64.
13. Ibrahim P. Studies on the growth cycle, isoniazid susceptibility of Mycobacterium avium. PhD thesis. University of Newcastle Upon Tyne, UK, 1996.
14. Besra GS, Minnikin DE, Wheeler PR, Ratledge C. Synthesis of methyl (z)-tetracos-5-enoate and enantiomers of ethyl (E)-6-methyltetracos-4-enoate; possible intermediates in the biosynthesis of mycolic acids in mycobacteria. Chem Phys Lipids 1993;66(1-2):23-34.
15. Goren JR, Cernich M, Brokl O. Some observations on mycobacterial acid-fastness. Am Rev Resp Dis 1978;118: 151-4.